Accendra Health (ACH) EBITDA Margin (2009 - 2026)
Accendra Health (ACH) posted quarterly EBITDA Margin of 2.73% for Q1 2026, down 21.0% year-over-year from 3.45% in Q1 2025, and down 7.51% quarter-over-quarter from 2.95% in Q4 2025.
Accendra Health (ACH) EBITDA Margin (2009 - 2026) Analysis & Trends
Accendra Health (ACH) has reported EBITDA Margin for 18 consecutive years, with 2.73% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin fell 21.0% year-over-year to 2.73%; the TTM figure through Mar 2026 stood at 0.91% (up 846.0% YoY), while the FY2025 annual figure was 0.99%, up 912.0% from the prior year.
- EBITDA Margin retreated to 2.73% in Q1 2026 per ACH's latest filing, from 2.95% in the prior quarter.
- Across five years, EBITDA Margin topped out at 4.52% in Q3 2024 and bottomed at 39.24% in Q4 2024.
- Historically, EBITDA Margin has averaged 1.14% across 5 years, with a median of 2.41% in 2022.
- Annual changes were most pronounced in 2024 — EBITDA Margin plunged 3750 bps — and 2025, when it jumped 4219 bps.
- Accendra Health's EBITDA Margin stood at 2.1% in 2022, then gained by 17 bps to 1.73% in 2023, then sank by 2166 bps to 39.24% in 2024, then soared by 108 bps to 2.95% in 2025, then declined by 8 bps to 2.73% in 2026.
- Business Quant data shows ACH's EBITDA Margin at 2.73% in Q1 2026, 2.95% in Q4 2025, and 3.8% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 1.25% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 1.50% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 1.14% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 4.95% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -60.84% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -5.73% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -0.84% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -14.82% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -6.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.73% |
| Mar 31, 2026 | 2.73% |
| Dec 31, 2025 | 2.95% |
| Sep 30, 2025 | 3.80% |
| Jun 30, 2025 | -5.82% |
| Mar 31, 2025 | 2.94% |
| Dec 31, 2024 | -39.24% |
| Sep 30, 2024 | 4.52% |
| Jun 30, 2024 | 2.56% |
| Mar 31, 2024 | 0.37% |
| Dec 31, 2023 | -1.73% |
| Sep 30, 2023 | 0.92% |
| Jun 30, 2023 | 0.42% |
| Mar 31, 2023 | 0.39% |
| Dec 31, 2022 | -2.10% |
| Sep 30, 2022 | 2.41% |
| Jun 30, 2022 | 3.00% |
| Mar 31, 2022 | 2.54% |
| Dec 31, 2021 | 2.51% |
| Sep 30, 2021 | 2.51% |